Abstract

OBJECTIVE

The study aimed to evaluate the risk of maternal death and fetal death among pregnant women infected with SARS-CoV-2.

METHODS

This is a retrospective cohort study among pregnant women with secondary data from the National Live Births System (Sistema Nacional de Nascidos Vivos), National Mortality System (Sistema Nacional de Mortalidade), and e-SUS Health Surveillance System (Sistema e-SUS Vigilância em Saúde). Pregnant women confirmed for COVID-19 had positive RT-PCR between March 2020 and May 2021, pregnant women without COVID-19 were those without notification for disease. Maternal death, fetal death, and stillbirth were assessed as primary outcomes.

RESULTS

We included 68,673 pregnant women not notified as suspected of COVID-19 and 1,386 with a confirmed diagnosis of COVID-19. Among pregnant women with COVID-19, 1013 (73.0%) were aged 20 to 34 years, 655 (47.2%) were brown, 907 (65.4%) had ≥ 8 years of education, in the third trimester of pregnancy (41.5%), undergoing cesarean section (64.5%). In adjusted analyses, COVID-19 in pregnancy had a higher risk of maternal death (relative risk [RR] 18.73-95% confidence interval [95%CI] 11.07-31.69), fetal death/stillbirth (RR 1.96-95%CI 1.18-3.25), preterm birth [RR 1.18-95%CI 1.01-1.39], cesarean delivery (RR 1.07-95%CI 1.02-1.11), and cesarean delivery occurring before the onset of labor (RR 1.33-95%CI 1.23-1.44).

CONCLUSION

COVID-19 may contribute to unfavorable pregnancy outcomes. Results showed that pregnant women infected with SARS-CoV-2 had a higher risk of maternal death, fetal death/stillbirth, preterm birth, cesarean delivery, and cesarean section occurring before the onset of labor.

MeSH

Pregnant Women, Pregnancy, Stillbirth, Parturition, Cohort Studies, Covid-19, Maternal Death, Fetal Death, Premature Birth, Cesarean Section

Cited by

• Reply to matters arising: Safety of SARS-CoV-2 vaccination during pregnancy - obstetric outcomes from a large cohort study: methodological biases in study design with potential impact on the study's interpretation. BMC Pregnancy Childbirth, 2025
• Space-time trends in fetal mortality in Brazil, 1996-2021. Rev Saude Publica, 2025
• Association between chronic health conditions and severe acute respiratory syndrome in pregnant women: an exploratory study. Rev Esc Enferm USP, 2024
• Impact of the COVID-19 pandemic on small vulnerable newborns: an interrupted time series analysis in Peru and Brazil. J Glob Health, 2025
• Pregnancy reduces COVID-19 vaccine immunity against novel variants. NPJ Vaccines, 2025
• Hospitalizations for coronavirus disease 2019: an analysis of the occurrence waves. Sci Rep, 2024
• Add-on hemoperfusion in SARS-CoV-2-infected pregnant patients: a case series. J Med Case Rep, 2024
• Fetal mortality before and during the COVID-19 pandemic: a single-center cohort study in Rio de Janeiro, Brazil. Rev Assoc Med Bras (1992), 2025
• Health system financing fragmentation and maternal mortality transition in Mexico, 2000-2022. Int J Equity Health, 2025
• Clinical characteristic and outcomes of pregnant women with COVID-19: The PROUDEST prospective cohort study. PLoS One, 2025
• Influence of sociodemographic and obstetric factors on maternal mortality in Brazil from 2011 to 2021. BMC Womens Health, 2024
• SARS-CoV-2 infection during pregnancy and the risk of adverse maternal outcomes in the Republic of Georgia: a national birth registry-based cohort study. BMC Pregnancy Childbirth, 2024